Fiche publication
Date publication
octobre 2020
Journal
The oncologist
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier
,
Pr MERROUCHE Yacine
,
Dr DEBREUVE-THERESETTE Adeline
Tous les auteurs :
Brugel M, Carlier C, Essner C, Debreuve-Theresette A, Beck MF, Merrouche Y, Bouché O
Lien Pubmed
Résumé
The coronavirus disease 2019 (COVID-19) pandemic may have affected cancer management. We aimed to evaluate changes in every oncology care pathway essential steps, from screening to treatment during the pandemic. Monthly oncological activity differences between 2019 and 2020 (screening tests, histopathological analyzes, multidisciplinary tumor board meetings (MTMB), diagnostic announcement procedures (DAP), and treatments) were calculated in two French areas experiencing different pandemic's intensity (Reims and Colmar). COVID-19 has had a dramatic impact in terms of screening (-86% to -100%), diagnosis (-39%) , and surgical treatment (-30%) . This global decrease in all essential oncology care pathway steps contrasted with the relative stability of chemotherapy (-9%) and radiotherapy use (-16%). Outbreak occurred earlier and with more intensity in Colmar but had a comparable impact in both areas regarding MTBM and DAP. The current ONCOCARE-COV study is still in progress, and with a longer follow-up to analyze post-lockdown situation.
Référence
Oncologist. 2020 Oct 28;:
